Oncology Pharma Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncology
SAN FRANCISCO, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to...
Month: February 2021
Casana Raises $14 Million in Series A Funding Led by General Catalyst for In-home Heart Health Monitoring Device
Company funded to develop visionary integrated IoT heart health device, in a toilet seat. Seasoned technology executive Austin McChord takes...
UPDATE – CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a...
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented positive pre-clinical data...
Mesa Labs Reports Third Quarter Results for FY21
LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”)...
eSight Receives Key Patents for Augmenting Sight Related to its Enhanced Vision Platform
Patents affirm the continued innovation and commitment to improving quality of life for individuals with low vision and legal blindnessTORONTO,...
Aligos Therapeutics Presents Data for its Chronic Hepatitis B Drug Candidates at the 30th Annual Conference of the Asian Pacific Association for the Study of the Liver
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...
Georgia Health Information Network Selects Velatura Public Benefit Corporation to Provide Advanced Technology Platform to Support Interoperability
ATLANTA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The Georgia Health Information Network (GaHIN), Georgia’s state-designated health information exchange (HIE), has...
Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
First-Of-Its-Kind Lab Test Helps Guide Targeted Treatment Decisions in Rheumatoid ArthritisWALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine,...
HMS Expands Work with World Trade Center Health Program to Support Member Coverage through Cost Containment Services
HMS’ proven success with workers’ compensation claim recovery efforts has resulted in more than $31 million in recoveries since 2015IRVING,...
Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD
VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
electroCore to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ROCKAWAY, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management...
Larry Diamond, CEO of Mitesco, Inc. and Michael Howe, CEO of The Good Clinic, are Featured in a New Audio Interview with SmallCapVoice.com
Interview provides insights and excitement surrounding MITI’s new clinic subsidiary “The Good Clinic (TM)” and the opening of its flagship...
Vystar Partners with Corrie MacColl For Market Development, Manufacturing, Sales & Distribution of Vytex® Deproteinized Latex
Corrie MacColl to produce Vytex from world’s largest rubber plantationWorcester, MA and Norfolk, VA, Feb. 03, 2021 (GLOBE NEWSWIRE) --...
Strongbridge Biopharma plc Announces New Employment Inducement Awards
DUBLIN, Ireland and TREVOSE, Pa., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical...
Enlivex Reports Positive Top-Line Results from Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients and Provides a Program Update
Phase II (16 patients treated, 9/16 (56%) with severe illness, 7/16 (44%) with critical illness, follow-up period of 28 days...
Mydecine Innovations Group Appoints Josephine Wu to Board of Directors
Provides update on U.S. OTC ListingDENVER, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE:...
Red Light Holland Announces $5 Million Bought Deal Equity Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 03, 2021...
Oxford Biomedica plc: Board Changes
Board Changes Oxford, UK – 3 February, 2021: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading...
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
Phase 1 study is designed to provide clinical proof-of-concept by taking advantage of established methods in endocrinologySAN DIEGO, Feb. 03,...